SIRO Clinpharm announces appointment of Gopakumar Menon as Chief Executive Officer to lead the global
Clinical Research Organization
Mumbai, India, March 6, 2012 - SIRO Clinpharm, a leading full service Clinical Research Organization announced the
appointment of Gopakumar Menon as Chief Executive Officer. SIRO has developed a long term plan to align with the changing dynamics
of the biopharma industry, and his primary charter is to transform SIRO into a global leader in the CRO and FSP space. He will be
responsible for continuing to build and enhance the biopharma service catalog for SIRO's global delivery model, across the Americas,
Europe and Asia.
"It is a pleasure to have Gopakumar on board. Gopakumar brings with him rich experience in driving business growth, and delivering
tremendous value for leading companies, including Fortune 1000 companies," said Dr. Gautam Daftary, Chairman of SIRO
Clinpharm. "Gopakumar has an excellent track record in cultivating partnership based relationships with Fortune 500 pharmaceutical
client base, envisioning cutting-edge business and technical solutions for clients across U.S., Europe, Japan, India, China and
Singapore. His experience and knowledge will help SIRO to enhance its services, and build a strong presence in new markets where
the company plans to expand its frontiers. "
"The biopharma industry is undergoing significant transformations. Clients are actively seeking quality service providers from the
emerging markets, who can understand their specific challenges, and partner to build and deliver innovative solutions in a global
delivery model." said Gopakumar. "My first priority will be to leverage decades of experience, tremendous value, and geographic
reach of SIRO to make it the partner of choice for business critical services of global biopharma leaders. I look forward to working
with Gautam and SIRO's board of directors."
Gopakumar has been with the pharmaceutical industry for the more than 12 years, where he worked in various capacities, from
discovery to sales and marketing.
Prior to joining SIRO Clinpharm, Gopakumar was with Boston based Sciformix Inc. Gopakumar has had significant experience working
with Fortune 500 companies like Cognizant and Satyam, in their Life Sciences divisions, as well as with venture funded start-up
SIRO Clinpharm, winner of Frost & Sullivan Indian Clinical Research Organization of the year 2011 award, is a drug development
solutions provider to the global healthcare industry. Our subject expertise gives us an edge in data management, medical writing,
biostatistics & clinical trial management. Having a successful track record of 16 years, SIRO works with most top global biopharma
& medical device companies. Our therapeutic experience includes but is not limited to oncology, diabetes, cardiology,
infectious diseases & respiratory system. We offer flexible business models across service verticals based on client
The company has offices in India, Malaysia, USA, and Israel and in Europe at Germany, Romania, Estonia, Greece, Czech Republic